Edition:
United Kingdom

X T L Biopharmaceuticals Ltd (XTLB.OQ)

XTLB.OQ on NASDAQ Stock Exchange Capital Market

2.64USD
16 Nov 2018
Change (% chg)

$-0.07 (-2.58%)
Prev Close
$2.71
Open
$2.79
Day's High
$2.93
Day's Low
$2.64
Volume
500
Avg. Vol
4,272
52-wk High
$3.91
52-wk Low
$1.58

Chart for

About

XTL Biopharmaceuticals Ltd. is a biopharmaceutical company. The Company focuses on the acquisition and development of pharmaceutical drugs for the treatment of medical needs. Its products include hCDR1 and Recombinant Human Erythropoietin (rHuEPO). hCDR1 is a Phase II-ready asset compound, working through a mechanism of action,... (more)
No analyst recommendations are available for .

Overall

Beta: -0.08
Market Cap(Mil.): $13.38
Shares Outstanding(Mil.): 5.14
Dividend: --
Yield (%): --

Financials

  XTLB.OQ Industry Sector
P/E (TTM): -- 83.95 33.59
EPS (TTM): -1.00 -- --
ROI: -70.95 -0.80 15.05
ROE: -125.01 -0.14 16.62

Earnings vs. Estimates